Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Altimmune (ALT) Non Operating Income (2016 - 2025)

Altimmune (ALT) has disclosed Non Operating Income for 16 consecutive years, with -$27000.0 as the latest value for Q4 2025.

  • Quarterly Non Operating Income fell 101.6% to -$27000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $678000.0 through Dec 2025, down 58.04% year-over-year, with the annual reading at -$190000.0 for FY2025, 102.34% down from the prior year.
  • Non Operating Income for Q4 2025 was -$27000.0 at Altimmune, up from -$86000.0 in the prior quarter.
  • The five-year high for Non Operating Income was $1.9 million in Q2 2023, with the low at -$306000.0 in Q3 2021.
  • Average Non Operating Income over 5 years is $418350.0, with a median of $19000.0 recorded in 2023.
  • The sharpest move saw Non Operating Income tumbled 1147.3% in 2021, then soared 8330.0% in 2024.
  • Over 5 years, Non Operating Income stood at -$102000.0 in 2021, then plummeted by 112.75% to -$217000.0 in 2022, then skyrocketed by 109.22% to $20000.0 in 2023, then skyrocketed by 8330.0% to $1.7 million in 2024, then crashed by 101.6% to -$27000.0 in 2025.
  • According to Business Quant data, Non Operating Income over the past three periods came in at -$27000.0, -$86000.0, and $776000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.